Abstract: Provided is a hemostatic dressing. The hemostatic dressing includes: a porous matrix layer including a biocompatible polymer; a hemostatic layer loaded on the porous matrix layer and including a polymer in which polyhydric phenol-containing moieties are introduced; and a binding layer interposed between the porous matrix layer and the hemostatic layer to prevent the porous matrix layer from being separated from the hemostatic layer.

Abstract: A CMP slurry composition for polishing copper and a copper film polishing method using the same, the CMP slurry composition includes a solvent; an abrasive agent; and a compound including a structural unit represented by Formula 1 or a compound including a structural unit represented by Formula 2,

Abstract: A method and a system thereof for establishing a model for assessing construction site risk levels through deriving BIM-based hazard factors are proposed. The method includes step S110 of collecting similar study trends, step S120 of analyzing a CSI hazard factor profile database, step S130 of collecting construction company development cases and trends, step S200 of establishing a classification system of a risk assessment DB (110) and including step S210 of systematizing a construction site category, step S220 of deriving a quantitative risk level calculation method, and step S230 of analyzing current risk assessment, step S300 of developing a framework and including step S310 of deriving a construction site hazard factor visualization method and step S320 of developing a risk assessment model framework, step S500 of transmitting BIM-based risk assessment model data, and receiving feedback including supplemented data, and step S600 of establishing the BIM-based risk assessment model.

Abstract: A substrate transfer robot for transferring a substrate in a vacuum chamber, includes: a transfer arm platform having coupling holes, wherein link connecting members with blades are engaged at front and rear areas of the transfer arm platform and a support shaft of a lower support is inserted into the lower space of one of the coupling holes; and a first and a second transfer arm part each including an end effector for supporting the substrate, multiple transfer link arms, multiple subordinate link arms and a common link arm that are connected to each other or to the transfer arm platform, wherein, the transfer link arms include at least some of drive shafts, interlocked with transfer driving motors or speed reducers, and output shafts interlocked with the drive shafts, and wherein the end effectors are positioned at different heights from each other through using a bracket.

Abstract: A substrate transfer robot for transferring a substrate in a vacuum chamber, includes: a transfer arm platform having coupling holes, each compartmentalized into a lower and an upper space, wherein link connecting members with blades are engaged at front and rear areas of the transfer arm platform and a support shaft of a lower support is inserted into the lower space of one of the coupling holes; and a first and a second transfer arm part each including an end effector for supporting the substrate, multiple transfer link arms, multiple subordinate link arms and a common link arm that are connected to each other or to the transfer arm platform, wherein, for each transfer arm part, drive shafts, interlocked with transfer driving motors or speed reducers installed on one of the transfer link arms, and output shafts interlocked with the drive shafts are installed on the transfer link arms.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: There is provided a method performed by a system for obtaining a relative location of an anchor-free UWB-based node. The method includes obtaining relative distances between a plurality of nodes based on UWB sensor values between the nodes, constructing a relative coordinate system having a center node of the plurality of nodes as a base, and calculating coordinate values of other nodes in the relative coordinate system. The constructing of the relative coordinate system having the center node of the plurality of nodes as a base includes constructing the relative coordinate system based on a relative distance between the center node and another node and absolute values of y axis values.

Abstract: An electrolyte solution for a lithium secondary battery includes an organic solvent, a lithium salt, and a fluorine-based additive in which a terminal difluoro-phosphite group (—OPF2) is bonded to a branched saturated hydrocarbon group. The fluorine-based additive prevent side reactions in the electrolyte solution to improve stability of a cathode active material.

Abstract: The present disclosure relates to a novel PLK1 degradation inducing compound, a method for preparing the same, and the use thereof. The compounds of the present disclosure exhibit an effect of inducing PLK1 degradation. Therefore, the compounds of the present disclosure may be effectively utilized for preventing or treating PLK1-related diseases.

Abstract: Provided are structural properties of double-stranded RNA molecules for inducing RNA interference, and more specifically, a novel nucleic acid molecule structure for inducing RNAi with improved stability, and a use thereof. A nucleic acid molecule for inducing RNAi provided herein is capable of significantly improving stability of a double-stranded RNA molecule in vivo while maintaining inhibition efficiency for a target gene, and therefore, as a expandable platform for targeting various genes, the RNA nucleic acid molecule is expected to replace siRNA molecules in the art, and be usefully utilized in the field of diagnosis or treatment of various diseases in research and clinical fields.

Abstract: Provided are a method of training a neural network model, a method of recognizing an acoustic event and an acoustic direction, and an electronic device for performing the methods. A method of training a neural network model according to an example embodiment includes generating a heatmap indicating an acoustic event and an acoustic direction in which the acoustic event occurs by using training data, outputting a result of recognizing the acoustic event and the acoustic direction by inputting a feature extracted using the training data into a neural network model for recognizing the acoustic event and the acoustic direction of the training data, and training the neural network model by using the result and the heatmap.

Abstract: Provided are a method of recognizing sound, a method of training a sound recognition model, and an electronic device performing the same methods. A method of training a sound recognition model according to an example embodiment may include converting training data labeled with a sound class into a feature vector, storing the feature vector in a feature queue, transferring the feature vector stored in the feature queue to a block queue according to an operation of a feature vector transfer timer, inputting the feature vector of the block queue into a sound recognition model trained to predict the sound class and storing an output result in a result queue, transferring the feature vector stored in the feature queue corresponding to timing at which the result is output to the block queue by the feature vector transfer timer when the result is output.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.

Abstract: A display device includes: a substrate including a first emission area, a second emission area, and a third emission area; a first wavelength conversion pattern overlapping the first emission area; a second wavelength conversion pattern overlapping the second emission area; and a light-transmitting pattern overlapping the third emission area, wherein the first wavelength conversion pattern includes first wavelength shifters configured to convert a first light into a second light, and first scatterers, the second wavelength conversion pattern includes second wavelength shifters configured to convert the first light into a third light, and second scatterers, and a ratio between a concentration of the first wavelength shifters and a concentration of the second wavelength shifters is 1:1.1 to 1:1.3.

Abstract: A DC-DC converter including a bridge circuit unit electrically connected to a DC link capacitor and comprising at least one full bridge circuit comprising switching elements; a sensing unit for sensing a voltage between the bridge circuit unit and the DC link capacitor; and a control unit for controlling the bridge circuit unit according to the sensed voltage, wherein a power of one end of a battery is controlled to a droop curve-shaped power value according to the sensed voltage, wherein the DC-DC converter further comprises an inductor and a capacitor electrically connected to the bridge circuit unit, the inductor is connected to one end of a battery, the capacitor is connected to one end of the battery and a node on the other end of the battery, and the node is connected to and arranged between the inductor and the battery.

Abstract: Disclosed is a substrate treating apparatus. The substrate treating apparatus includes a chamber providing a space in which a substrate is treated, a support unit supporting the substrate inside the chamber, a laser unit irradiating laser to an edge region of the substrate, a vision unit capturing the edge region of the substrate to measure an offset value of the substrate, and an adjustment unit adjusting an irradiation location of the laser based on the offset value of the substrate.

Abstract: A display device is provided. The display device comprises a substrate, contact electrodes and a common contact electrode on the substrate, light-emitting elements on the contact electrodes, and a common connecting electrode on the common contact electrode and connected to the light-emitting elements, wherein the common connecting electrode includes first conductive patterns, which are in contact with the common contact electrode.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.

Abstract: The present disclosure provides adenosine receptor (e.g., A2A and/or A1 receptor) antagonist compounds and compositions including said compounds. The present disclosure also provides methods of using said compounds and compositions for modulating (e.g., inhibiting or antagonizing) A2A and/or A1 receptor in a biological system. The compounds and compositions find use in various therapeutic applications including the treatment of cancer and in immuno-oncology. The compounds and compositions find use in various therapeutic applications including the treatment of central nervous system or neurodegenerative diseases, such as Parkinson’s disease.

Abstract: The present invention provides novel compounds that induce selective polo-like kinase 1 (PLK1) degradation. Specifically, the present invention provides a bifunctional compound in which a PLK1 binding moiety and an E3 ubiquitin ligase-binding moiety are linked by a chemical linker. The present invention provides the compound, a method for preparing the same, and the use thereof. The compounds may be effectively utilized for preventing or treating PLK1 related diseases.